NewBridge Pharmaceuticals is a leading brand in the healthcare industry, offering a wide range of products and services to meet the needs of patients and healthcare professionals. With a focus on therapy areas such as Gastroenterology, Genomics, Immunology, Neuroscience, Oncology/Hematology, and Rare Diseases, NewBridge is dedicated to providing innovative solutions that improve patient outcomes. At NewBridge, we believe in the power of collaboration, which is why we actively seek partnerships with like-minded organizations to further advance medical research and development. Our dedicated team of professionals, including our experienced executive team and board of directors, ensures that we are at the forefront of medical advancements, consistently delivering high-quality products and services. Our in-house capabilities span across various departments, including Regulatory Affairs, Market Access, Medical Affairs, Sales & Marketing, Finance, Supply Chain & Logistics, Pharmacovigilance, Quality, Legal & Compliance, Information Technology, and Human Resources. This comprehensive approach allows us to provide holistic and effective solutions to our customers. With our commitment to ethics and compliance, NewBridge adheres to the highest standards of business conduct, ensuring transparency and integrity in all our operations. Additionally, we offer an Early Access Program, enabling patients to access innovative therapies before they are widely available. To learn more about NewBridge Pharmaceuticals and our offerings, please visit our website or contact us directly. We are dedicated to making a positive impact on healthcare worldwide.
Learn more
Dubai Story Desk — expanded profile compiled from the company’s public website and about materials. Not sponsored; facts may change—verify on the official site.